Repare Therapeutics (RPTX)
(Delayed Data from NSDQ)
$1.71 USD
-0.06 (-3.12%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.74 +0.03 (1.75%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Repare Therapeutics Inc. has a market cap of $75.82M, which represents its share price of $1.77 multiplied by its outstanding shares number of 42.96M. As a small-cap company, RPTX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
RPTX 1.71 -0.06(-3.12%)
Will RPTX be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RPTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RPTX
Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates
CervoMed Inc. (CRVO) Reports Q1 Loss, Tops Revenue Estimates
RPTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Makes Repare Therapeutics (RPTX) a New Buy Stock
Myriad Genetics (MYGN) Meets Q4 Earnings Estimates
Repare Therapeutics (RPTX) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
Other News for RPTX
1,2,3 Pullback Bullish appears for RPTX after 3.12% move
Technical picture remains unchanged for RPTX after it rises 1.44% on September 19
Sideways movement on September 17 results in no shift to RPTX’s technical outlook
RPTX's price falls by 1.42% on September 16, though its technical setup remains stable.
NR7 appears for RPTX after 0.28% move